GT Biopharma, Inc. (OTCMKTS: GTBP) had a great day in the market yesterday and I’m expecting that the positive movement will continue. The gains came after the company announced an update with regard to its COVID-19 development program. Here’s what’s going on: GTBP Stock Gains On COVID-19 Update In the press release, GT Biopharma provided … Read more
GT Biopharma, Inc. (OTCMKTS: GTBP) is setting the stage for a strong day in the market today after announcing positive data from and the advancement of a Phase I/II clinical trial. Here’s what’s going on: GTBP Announces The Advancement Of Its TriKE Clinical Trial In the press release, GT Biopharma said that it has completed … Read more
GT Biopharma (OTCMKTS: GTBP) has set the foundation for strong growth ahead. The company announced that it has completed a private offering, even in the midst of the COVID-19 pandemic. Moreover, as the company sets up for a major uplisting, the stock deserves your attention. Here’s what’s going on: Stop wasting your time! Start finding … Read more
GT Biopharma (OTCMKTS: GTBP) is a stock that I’ve been watching for some time now, and with today’s news, I’m glad it’s on my radar. In a press release issued early this morning, the company announced it has begun treatment of the second patient in a Phase I/II clinical trial. Here’s what’s going on: Stop … Read more
GT Biopharma Inc (OTCMKTS: GTBP) is one of my favorite stocks in the coronavirus space. The company’s TriKE, an NK cell engager, has generated incredibly positive data. While this data was not in a COVID-19 patient, it is the same technology and same response that we hope to see among COVID-19 patients, making the data … Read more
The coronavirus is no laughing matter. So far, the virus has infected around 200,000 people with more than 7,000 deaths around the world. In fact, the condition is so serious that it’s changing the shape of the United States as we know it. Schools are shutting their doors for weeks at a time, concerts are … Read more
GT Biopharma Inc (OTCMKTS: GTBP) is setting the stage for a strong day ahead in the market today, and for good reason. The company issued a press release announcing positive data from an oncology clinical trial. However, with the product also being assessed as a potential option to treat the novel coronavirus, this is likely … Read more
Recently, we’ve seen iBio (NYSEAMERICAN: IBIO), Novavax (NASDAQ: NVAX) and AIM ImmunoTech (NYSEAMERICAN: AIM) make runs for the top on coronavirus news. While the boat may have sailed on those runs, another company, GT Biopharma Inc (OTCMKTS: GTBP) is likely the next candidate to see tremendous COVID-19 related gains. Here’s why: Stop wasting your time! … Read more